CLI Ventures
CLI Ventures is a global tech and healthcare VC firm.
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at CLI Ventures.
CLI Ventures is a global tech and healthcare VC firm.
Key people at CLI Ventures.
CLI Ventures is a global venture capital firm headquartered in Palo Alto, California, that invests primarily in early to late-stage companies within the healthcare, biotechnology, and software sectors. Its mission centers on supporting visionary founders and advancing innovative technologies that shape the future, particularly in healthcare and life sciences. The firm’s investment philosophy emphasizes backing companies with strong growth potential, often participating in rounds alongside notable investors like Y Combinator and Andreessen Horowitz. CLI Ventures plays a significant role in the startup ecosystem by providing capital and strategic support to companies developing breakthrough solutions in biotech, healthcare diagnostics, and technology-driven platforms[1][2][3].
Founded in 2010 in the United States, CLI Ventures has evolved to focus on sectors such as biotechnology, robotics, healthcare, and software. The firm’s founding partners and key team members have guided it through a trajectory marked by multi-IPO and M&A exits, reflecting a maturing investment approach that spans seed to later-stage rounds. Over time, CLI Ventures has built a reputation for investing in companies typically 2-3 years old, with a preference for startups valued between $10 million and $50 million at the time of investment. Its portfolio includes notable companies like CRISPR Therapeutics, Guardant Health, and Compass, which exemplify its focus on transformative healthcare and technology innovations[2][3].
CLI Ventures is positioned at the intersection of healthcare innovation and advanced technology, riding the wave of increased demand for biotech solutions, gene editing, and digital health platforms. The timing is favorable due to accelerating scientific breakthroughs (e.g., CRISPR gene editing), growing healthcare data utilization, and rising investment in life sciences. Market forces such as aging populations and the need for precision medicine amplify the firm’s impact. By backing companies that address these trends, CLI Ventures influences the broader ecosystem by fostering innovation that can lead to improved patient outcomes and new technology paradigms[3][2].
Looking ahead, CLI Ventures is likely to deepen its focus on cutting-edge healthcare technologies, including gene editing, diagnostics, and AI-driven health platforms, capitalizing on ongoing scientific advances and regulatory progress. The firm’s influence may expand as it continues to support startups that bridge biotech and software, shaping the future of personalized medicine and digital health. Trends such as increased healthcare digitization and precision therapies will likely drive CLI Ventures’ investment strategy, reinforcing its role as a key player in the evolving tech and healthcare venture capital landscape[3][2].
Key people at CLI Ventures.
